MedPlus Health Services Limited has announced a proposal for the buyback of its fully paid-up equity shares through the open market route. The company’s Board of Directors approved the buyback, which is set to not exceed ₹130 crore in aggregate. The maximum price for the buyback has been fixed at ₹750 per equity share. This strategic move aims to optimize returns and enhance shareholder value.
MedPlus Health Services Announces Share Buyback
MedPlus Health Services Limited has officially initiated a process to buy back its own equity shares. This strategic decision, approved by the Board of Directors on November 6, 2026, will be executed through the open market route via stock exchanges. The buyback aims to enhance overall shareholder value and optimize the company’s capital structure.
Key Details of the Buyback
- Aggregate Buyback Value: Up to ₹130 crore (Indian Rupees One Hundred and Thirty Crores only).
- Maximum Buyback Price: Not exceeding ₹750 (Indian Rupees Seven Hundred and Fifty only) per equity share.
- Indicative Number of Shares: Approximately 17,33,333 equity shares, representing about 14.42% of the total paid-up equity share capital as on November 6, 2026.
- Buyback Period: The buyback will open on Friday, November 13, 2026, and will close within 66 working days from the opening date, or earlier if 75% of the maximum buyback size is utilized.
- Source of Funds: The buyback will be funded from the company’s securities premium account, free reserves, and cash and cash equivalents, not from borrowed funds.
Regulatory Compliance and Public Announcement
The buyback is being conducted in accordance with the provisions of the Companies Act, 2013, and the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018. A public announcement regarding the buyback was published on November 9, 2026, in leading newspapers including Financial Express (English), Jansatta (Hindi), and Nava Telangana (Telugu).
The company has confirmed that the buyback will not result in a change in control or management and will not lead to the delisting of its shares from the stock exchanges. Information related to the buyback will also be available on the company’s website, www.medplusindia.com.
Source: BSE
